BEST UNLIMITED TURBO LONG CERTIFICATE - IPSEN | Real-time Euronext Paris 05:03:54 15/05/2024 pm IST | ||
| 1.205 EUR | -2.43% |
|
| Current month | +41.14% | ||
| 1 month | +94.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 15/24/15 | 1.205 | -2.43% |
| 14/24/14 | 1.235 | +11.76% |
| 13/24/13 | 1.105 | -2.64% |
| 10/24/10 | 1.135 | 0.00% |
| 09/24/09 | 1.135 | +16.41% |
Real-time Euronext Paris
Last update May 15, 2024 at 05:03 pm IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 93E4S | |
| ISIN | DE000SN4ES91 |
| Date issued | 05/07/2022 |
| Strike | 97.57 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.41 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.975 € |
|---|---|
| Lowest since issue | 0.215 € |
| Spread | 0.01 € |
| Spread % | 0.83% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
121.4
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.07%
- Stock Market
- Certificates
- 93E4S Certificat